Background In a previous study, we found that neonatal sympathectomy prevented the development of angiotensin II (ANG II)-induced hypertension but not the development of structural changes in small mesenteric arteries.
Introduction
The hallmark of chronic hypertension is the development of structural vascular changes, and an increase in wall : lumen ratio (WLR) is the predominant lesion [1] [2] [3] [4] . An increase in WLR does not necessarily indicate that vessel wall area has increased (hypertrophy) but could be due to a decrease in lumen (remodeling). In the genetic forms of hypertension, including human essential hypertension, remodeling of resistance arteries appears to play an important role. In the rat models of experimental hypertension, on the other hand, much of the altered structure is due to vascular growth associated with hypertrophy of vascular smooth muscle cells. Whether structural vascular changes are primary or secondary to blood pressure elevation remains an unsettled issue. In the majority of studies of hypertension, a direct relationship between blood pressure elevation and WLR has been found, but discrepancies also exist. It has been proposed that trophic stimulation of vascular muscle alone might be sufficient to induce structural vascular changes and, thereby, initiate the hypertensive process. Angiotensin II (ANG II) has been a prime candidate for such a trophic factor [5] . The trophic effects of ANG II may be reinforced by concomitant activation of the sympathetic nervous system, which could have trophic properties of its own [5] . Previous investigations of the administration of ANG II to rats [6] , including our own [7] , revealed medial thickening due to hypertrophy of large and small mesenteric arteries. Medial thickening of large arteries was not prevented by antihypertensive therapy with hydralazine, suggesting that pressure-independent mechanisms were also operating [6] . In our previous study, structural changes in small resistance arteries (< 120 m outer diameter) seemed to precede the development of structural changes in intermediate-size arteries (120-220 m outer diameter) and the onset of hypertension [7] .
The present study is an extension of a previous one in which we found that neonatal sympathectomy prevented the development of hypertension and vascular hyperreactivity in ANG II-treated rats but not the development of structural changes in small mesenteric arteries [8] . The purpose of the present study was to investigate this dissociation between hypertension and structural vascular changes in greater detail, using tissue specimens preserved from this previous study. Morphometric measurements were extended to all segments of the mesenteric arterial tree, including the large arteries. Investigation of large arteries permitted us to determine whether structural vascular changes induced by ANG II were due to remodeling, hypertrophy or hyperplasia.
Methods

Preparation of rats
Sympathectomized and sham-sympathectomized male Sprague-Dawley rats were obtained from Zivic-Miller Laboratories (Zellenople, Pennsylvania, USA). Male rats were used to eliminate changes in the renin-angiotensin system in female rats that accompany the estrous cycle. Sympathectomy was performed according to the methods of Johnson et al. [9] . Beginning when the rats were aged 7 days, they were injected once daily for five consecutive days within a 3-week period for a total of 15 injections with 50 mg/kg guanethidine sulfate in isotonic saline with pH adjusted to 7.0-7.5 with sulfuric acid. Control animals were injected with corresponding amounts of isotonic saline. Bilateral adrenal demedullation or sham surgery was performed in all rats when they were aged 28 days. The rats were shipped to Minneapolis when they were aged 3 months. That peripheral sympathectomy in our study was of high degree was demonstrated by hypersensitivity of the rats to the vasoconstrictor action of norepinephrine and by a greater than 90% reduction in vasoconstrictor response to periarterial nerve stimulation of the mesenteric circulation of rats [8] .
To produce hypertension, synthetic ANG II (Asp-ArgVal-Tyr-Ile-His-Pro-Phe) (Sigma Chemical Co., St Louis, Missouri, USA) was infused continuously into rats subcutaneously for 4 weeks via an osmotic minipump (model 2ML4; Alza, Palo Alto, California, USA). To fill the minipumps, ANG II was dissolved in saline. Acetic acid (final concentration 0.01 mol/l) was added to maintain the stability of ANG II. The rate of delivery of ANG II was 200 ng/kg per min, on the basis of the body weight of the rat at the time of the insertion of the minipump. Control rats were fitted with empty, re-sterilized minipumps to reduce costs. The rate of delivery via the minipump was 2.5 l/h, and, in previous experiments, we found that the delivery of this much vehicle into control rats had no detectable metabolic or hemodynamic effect [10] . For insertion of the minipump, the rats were anesthetized with methoxyflurane, and the minipump was inserted subcutaneously through a 1.5 cm incision in the nape of the rat's neck. The rats had free access to tap water and ate standard chow (Ralston Purina 5002, 115 mmol/kg sodium and 250 mmol/kg potassium; Ralston, St Louis, Missouri, USA).
Systolic blood pressure (SBP) in restrained awake rats was measured by the tail-cuff method (Narco Biosystems, Inc., Houston, Texas, USA). Measurements were obtained on at least two occasions prior to the insertion of the minipump to rule out the possibility that rats had spontaneous hypertension (SBP > 130 mmHg). Rats whose SBP repeatedly exceeded 130 mmHg were rejected from the study. Thereafter, the SBP of rats was measured once a week until the completion of the experiment. On each occasion, SBP was recorded three or more times, and the measurements were averaged. Blood pressure load during the 4-week treatment period was calculated as the average weekly blood pressure of rats. The rats were weighed to within the nearest 1 g on the day of the final experiments.
In-situ tissue fixation
The right jugular vein of methoxyflurane-anesthetized rats was catheterized (PE 50), and 75 mg/kg chloralose, was administered intravenously. The rats were allowed to breathe spontaneously through a tracheostomy tube (PE 240). The superior mesenteric artery circulation of rats was pump-perfused in situ through a midabdominal incision with the rats' own aortic blood, as described by Jackson and Campbell [11] . First, vasoconstrictor responses to graded doses of ANG II, norepinephrine, and arginine vasopressin, and to periarterial nerve stimulation were measured. The results of these experiments have already been published [8] . After completion of the mesenteric hemodynamic measurements, the rats were injected with 1 mg per rat papaverine intravenously. The rats were killed 1-2 min later with an overdose of papaverine. Perfusion of the mesenteric vascular bed was continued with aerated (5% CO 2 -95% O 2 ) Krebs-Ringer bicarbonate solution at 37°C, to which 75 g/ml papaverine had been added. The portal vein was cut open to allow free circulation of the perfusate through the mesentery. Perfusion pressure was kept at 55-60 mmHg in all rats by adjusting the pump flow as needed. The pressure range 55-60 mmHg was chosen because we had found previously that after maximal systemic vasodilatation, mean arterial pressure falls to this level both in ANG II-treated and in control rats [12] . The mesenteric vascular bed was perfused sequentially with Krebs-Ringer solution for 10 min, fixative containing 2.5% glutaraldehyde, 1.86% sucrose, and 0.063 mol/l phosphate buffer (pH 7.4, 400 mOsm) for 20 min, and 0.200 mol/l phosphate buffer for 10 min. At the end of the perfusion, the entire small intestine and mesenteric vascular arcade were removed and preserved in 10% buffered formalin.
Morphometric measurements of large arteries
Counting from the illeocecal junction proximally, the sixth-ninth mesenteric vascular arcades were identified. Two vascular arcades with a Y configuration of the firstand second-order branches of the superior mesenteric artery were excised. The arteries were cleaned of adhering tissue, dehydrated through graded series of ethanol, and infiltrated and embedded in epoxy. Cross-sectional cuts, 0.5 m thick, of the two first-order arteries were made at two points and of the four second-order arteries at one point using a microtome. The sections were stained with methylene blue. A video camera (Cell Analysis Systems, Inc., Lombard, Illinois, USA) connected to an image analysis processor (NIH Image 1.54, public domain software) and a microcomputer was used to measure vessel and lumen diameters, wall thickness, and medial wall and lumen areas. WLR and medial : luminal area ratio were calculated. Vessels with broken or deformed wall were not measured. For a given rat, measurements taken for first-and second-order arteries, respectively, were averaged. The experimenter was blinded concerning the treatment of the rat. Remodeling and growth indices of first-and second-order arteries of ANG II-treated rats were calculated according to the formulae published by Heagerty et al. [3] . Remodeling index was defined as the percentage of the observed difference in lumen diameter of hypertensive and normotensive arteries that could be accounted for by remodeling of the normotensive artery. A remodeling index of 100% indicated that the differences between the WLR of arteries in hypertensive and normotensive rats were entirely due to a change in lumen diameter. A remodeling index greater than 100% indicated that vascular muscle growth accounts in part for increased WLR of arteries in hypertensive rats. The growth index was an estimate of the magnitude of this growth.
To count the number of nuclei per unit length of vessel wall, first-order arteries were embedded in paraffin, stained with hematoxylin and eosin, and sectioned along their longitudinal axis [13] . Using this sectioning, the nuclei of vascular muscle were cut transversely because smooth muscle cells typically wrap themselves around the vessel wall in concentric fashion. The number of nuclei was counted under ×450 magnification over 1.2-2.5 cm of vessel wall with a calibrated filar micrometer. Results were expressed as number of nuclei/100 m length.
Morphometric measurement of small arteries
The small intestine was cut into 2-3 cm segments, each segment retaining its own vascular arcade. A wooden stick was inserted into the lumen of the intestinal segments to straighten the junction of the intestinal wall and the vascular arcade where the cuts for histologic sections were going to be made. Three or four intestinal segments were dehydrated through graded series of ethanol concentrations, infiltrated with, and embedded in, paraffin. The intestinal segments were positioned in paraffin in such a manner as to permit cross-sectional cuts of mesenteric arteries. Sections 4 m thick were stained with hematoxylin and eosin. Two criteria were used to select arteries for morphometric measurements. First, by inspection, the thickness of the vessel wall had to be uniform throughout its circumference. Second, only vessels with a long : short axis ratio < 1.30 were measured, thus excluding vessels cut at greater than 40°from cross-section. In the present study, two categories of small resistance arteries, with external diameters in the ranges 50-100 (small) and 100-150 m (intermediate size), were investigated. Morphometric measurements of external and lumen diameter along the long and short axes of cross-sectionally cut arteries were obtained under ×450 magnification with a calibrated filar micrometer. The two measurements of external and lumen diameters were averaged. The observer was blinded concerning the treatment of the rat. Measurements were performed on a minimum of four cross-sectionally cut arteries for each category of vessels. Wall thickness, WLR, and the mean of each parameter were calculated for each rat.
Statistical analysis
Results are presented as means ± SEM. Two-way analysis of variance (factor 1: sham-sympathectomy or sympathectomy; factor 2: control or ANG II treatment; Superanova; ABACUS Concepts, Berkeley, California, USA) was used to compare SBP and vessel dimensions among the four groups of rats (Fig. 1, Table 1 ). For comparisons of SBP, the average weekly blood pressure of rats during the 4-week treatment period was calculated. When the term Px for interaction between ANG treatment and sympathectomy was not significant, the effects of the two interventions were analyzed separately. This is indicated by the variables pSx and pANG II in Table  1 . When there was a significant interaction between the two interventions, statistical analysis, using preplanned contrasts (Superanova), was confined to comparisons of the effects of ANG II and control treatment between sham-sympathectomized and sympathectomized rats (Table 1 ). In the case of small arteries, statistical analysis of vessel dimensions was restricted to WLR because the possibility of selection bias could not be excluded, considering that measurements were performed only on crosssectionally cut arteries. WLR remain relatively unchanged despite differences in lumen diameter as long as a small range of diameters is being measured and are, therefore, less affected by sampling bias than are measurements of external and lumen diameters and wall thickness [4] . WLR of small arteries of sham-sympathectomized and sympathectomized ANG II-treated rats was correlated to their average weekly SBP by linear regression analysis. P < 0.05 was considered statistically significant.
Results
By inspection, all rats remained healthy during the 4-week treatment period. Except for their exhibiting ptosis, sympathectomized rats were indistinguishable from shamsympathectomized rats [9] . The body weight of rats was in the range 480-600 g at the end of the experiments and did not differ among the groups [8] . The tail SBP of rats are shown in Figure 1 . In regard to SBP, there was a significant interaction between the effects of sympathectomy and of ANG II treatment (P < 0.02, Table 1 ); without sympathectomy, ANG II treatment resulted in a significant rise in SBP (P < 0.001), whereas the rise in SBP in sympathectomized rats during ANG II treatment did not attain statistical significance. (At the end of 4 weeks of treatment, direct measurement of mean arterial pressure in these same rats, under chloralose anesthesia, confirmed the conclusions of the non-invasive measurements of blood pressure. Mean arterial pressure in ANG II-treated sham-sympathectomized rats increased but it remained unchanged in ANG II-treated sympathectomized rats [8] .)
Weekly tail systolic blood pressures (BP, means ± SEM) of angiotensin II (ANG II)-treated (open symbols) and control (solid symbols) sham-sympathectomized (solid lines) and sympathectomized (dashed lines) rats. ᭺, ANG II (n = 11); ᭝, sympathectomized plus ANG II (n = 10); ᭹, control (n = 8); ᭡, sympathectomized control (n = 6). P < 0.001, versus shamsympathectomized controls (solid circles). Values are means ± SEM. pSX, sympathectomy alone; pANG II, angiotensin II alone; Px, interaction term; SXY, sympathectomy; ND, not done; WLR, wall : lumen ratio; WALAR, medial wall : lumen area ratio.
The morphometric measurements of first-order arteries are summarized in Table 1 . ANG II and sympathectomy had independent effects on vessel morphology. ANG II treatment caused a significant increase in vessel and lumen diameters, wall thickness, and vessel, lumen, and medial wall areas. Sympathectomy, on the other hand, resulted in minor increases in vessel dimensions but highly significant reductions in WLR and wall : lumen area ratio. On comparing the effects of ANG II and control treatment on sham-sympathectomized and sympathectomized rats by preplanned contrasts (Table 1) , some important quantitative differences between the responses of rats of the two groups were observed. Although an increase in vessel area occurred in rats of both groups during ANG II treatment, a significant increase in wall thickness and wall area occurred only in sham-sympathectomized rats. The increase in wall thickness and wall area of first-order arteries in ANG II-treated sympathectomized rats did not attain statistical significance (P = 0.36 and 0.22, respectively). It should be noted, however, that the power of these statistical tests (1 − ␤, where ␤ is the probability of accepting a false null hypothesis) was low due to the small number of observations and the unbalanced sample sizes of the experimental groups. Morphometric measurements of second-order arteries revealed the same effects of ANG II treatment and of sympathectomy as those that had been observed for the first-order arteries. Because the results differed only in the overall dimensions of vessels, the results from morphometric measurements of second-order arteries are not shown. The remodeling and growth indexes of first and second-order arteries in sham-sympathectomized ANG II-treated rats were 134 and 137%, and 58 and 54%, respectively. The first set of numbers indicates that, in addition to a change in lumen diameter, there was also growth of these arteries. The second set of numbers is a measure of the extent of this growth. The remodeling and growth indexes of first and second-order arteries in sympathectomized ANG II-treated rats were 118 and 112%, and 28 and 18%, respectively, indicating that a marked attenuation of ANG II-induced growth had occurred. Finally, like in the case of SBP, ANG II treatment and sympathectomy interacted in determining the number of nuclei per vessel wall length in first-order arteries (Table 1) ; we observed an increase in number of nuclei only in ANG II-treated sham-sympathectomized rats. The excess nuclei appeared in clusters rather than being evenly distributed along the length of the vessels.
The morphometric measurements of small (50-100 m outer diameter) and intermediate-size (100-150 m outer diameter) resistance arteries of sham-sympathectomized and sympathectomized rats are shown in Tables 1 and 2 . Microscopic examination of small resistance arteries revealed hyperplastic arteritis in five ANG II-treated sham-sympathectomized (intact) rats and in five ANG IItreated sympathectomized rats despite the fact that hypertension was markedly attenuated in the latter. In three sham-sympathectomized and two sympathectomized rats the changes were so severe (Fig. 2 ) that calculated WLR exceeded 20%. The small artery dimensions of these rats were excluded from the analysis of results (Table 2) . There was only a scattering of hyperplastic small arteries in the remaining rats. Measurements in these rats were confined to the unaffected small arteries. Like in the case of first-order arteries, there was no interaction between the effects of ANG II treatment and sympathectomy in determining the WLR of resistance arteries. ANG II treatment caused an increase in WLR both of small and of intermediate-size resistance arteries. Compared with that in control rats, using preplanned contrasts, the increase in WLR of resistance arteries in sham-sympathectomized and sympathectomized rats was of the same magnitude. This is in sharp contrast to that which was observed in first-order (conduit) arteries, where the increases in wall thickness and wall area were limited to shamsympathectomized rats. The WLR of intermediate-size resistance arteries in severely hypertensive sham-sympathectomized ANG II-treated rats was correlated directly to the blood pressure load to which the rats had been exposed during the 4-week treatment period (r = 0.61, n = 11, P < 0.05). We found no such correlation for sympathectomized ANG II-treated rats (r = 0.09, n = 8, NS). Measurements of intermediate-size arteries have previously been published [8] .
Discussion
Morphometric measurements of mesenteric arteries in rat models of hypertension have been performed using myographic and morphometric techniques [1, 14] . For the most part, use of myographic techniques has been confined to vessels with external diameters greater than 250 m [1, 6] . Lee et al. [14] developed techniques that permitted morphometric measurements on mesenteric arteries with external diameters in the 120-150 m range, slightly larger than the intermediate-size arteries investigated in the present study. These vessels were dissected out individually after in-situ perfusion fixation at low pressures to avoid expansion of the vessel wall. Individual handling of blood vessels might introduce a selection bias that is difficult to control unless the experimenter is not aware of the type of rat that is being investigated and of the type of treatment of the rat. In the present study, the small mesenteric arteries were not dissected out individually; instead the intestinal-mesenteric junction was embedded and sectioned en bloc. The selection of arteries to be measured was left to chance insofar as measurements were limited to cross-sectionally cut vessels. The techniques used by us also permitted measurements to be performed on arteries with external diameters in the 50-100 m range, some of which may be considered arterioles.
Sympathectomy alone resulted in an increase in dimensions and decreases in WLR and wall : lumen area ratio of first-and second-order branches of the superior mesenteric artery (large arteries). An increase in vessel lumen accompanied by a decrease in WLR was termed hypotrophic outward remodeling [15] . A trophic effect of sympathectomy on vessel dimensions had previously been reported by Bevan [16] . Bevan found that denervation resulted in decreases in wall thickness, WLR, and medial wall area of rabbit central ear artery. However, in contrast to our findings, the lumen diameter of the denervated artery was decreased rather than increased. In our study, neonatal sympathectomy had no significant effect on WLR of small mesenteric resistance arteries (Tables  1, 2 ).
There were also important differences between the responses of small and large arteries to ANG II treatment and in the effect of neonatal sympathectomy on these responses. With the development of severe hypertension in ANG II-treated sham-sympathectomized (intact) rats, the large arteries underwent a marked increase in medial wall area and dilated at the same time. Calculated remodeling and growth indexes showed that restructuring of the vessel wall was not limited to an increase in lumen diameter; there was also an increase in the volume of vascular muscle. These changes were termed hypertrophic outward remodeling [15] . Whether the trophic change was due to hypertrophy or hyperplasia of vascular muscle, or both, was not established. The finding that the extra nuclei per unit length of vessel wall were found in clus- Values are means ± SEM. For statistical analysis of wall : lumen ratios (WLR), see Table 1 .
ters rather than being uniformly distributed along the vessel wall suggests that we were observing polyploidy rather than hyperplasia of vascular muscle. This remains, however, a tentative conclusion. Polyploidy of large arteries has been found to occur in several experimental models of hypertension in which blood pressure rose rapidly and reached severely hypertensive levels [17] . These changes in large artery structure were attenuated by neonatal sympathectomy of rats along with the marked attenuation of hypertension. The findings suggest that either severe hypertension or sympathetic innervation, or both, is required for the development of structural changes in the large mesenteric arteries of ANG II-treated rats.
In contrast to the case of large arteries, there was a clear dissociation between blood pressure and structure of small arteries in ANG II-treated sympathectomized and shamsympathectomized rats. Like in our previous study [7] , ANG II treatment resulted in an increase in WLR of small resistance arteries. The extent of structural changes was, however, the same in sympathectomized and shamsympathectomized ANG II-treated rats despite there being a large difference between their blood pressures. The extent of structural changes in sympathectomized ANG II-treated rats was not related to the blood pressure load. If we were to plot the blood pressure loads of rats of all four groups (Fig. 1) against the WLR of their small arteries, a clear dissociation of the two parameters would be apparent. These findings suggest that ANG II had a direct effect on small artery structure.
The different responses of small and large mesenteric arteries in ANG II-treated sympathectomized rats may be explained on the basis of the relative distributions of sympathetic innervation and ANG II receptors. This suggestion is based on hemodynamic measurements conducted by Christensen et al. [18] . Those authors were able to place indwelling catheters into large and small mesenteric arteries of rats so that segmental resistances could be measured directly. Injection of norepinephrine into awake rats resulted in uniform constriction of all segments of the mesenteric arterial tree, but the vasoconstrictor action of ANG II was limited to small arteries. The findings suggest that density or sensitivity, or both, of ANG II receptors is greater in small than it is in large arteries, and, therefore, structural changes in small arteries may be the result of a direct trophic action of ANG II. For the development of structural changes in large arteries, on the other hand, the contributions of ANG IIinduced hypertension and sympathetic activity may be also required. That ANG II can potentiate sympathetic vasoconstrictor tone by altering the uptake and release of norepinephrine at nerve terminals has been known for some time [19] . The present findings suggest that there could be also an interaction between the trophic effects of the two systems.
In regard to large arteries, our findings differ somewhat from the findings of Griffin et al. [6] but are in agreement with those of Levy et al. [20] , who found outward hypertrophic remodeling of the carotid artery, along with an increase in number of nuclei, in ANG II-treated rats. Griffin et al. [6] investigated large mesenteric artery (> 250 m outer diameter) structure in ANG II-treated rats using myographic techniques. They found increases in wall thickness and medial wall area of large arteries like we did but no change in lumen diameter. Consequently, the calculated WLR of arteries was greater. However, Griffin et al. [6] performed their morphometric measurements while the arteries were incubated in a physiologic salt solution and, therefore, under active tension. We, in contrast, fixed the arteries at maximal vasodilatation. Another important difference between our results and theirs is the effect of antihypertensive treatment on the development of structural changes in large arteries. Hydralazine treatment in the study of Griffin et al. [6] prevented the development of ANG II-induced hypertension but not the hypertrophic remodeling of arteries, suggesting that the trophic changes were the result of a direct action of ANG II on the vessel wall. In our study, neonatal sympathectomy attenuated both the hypertension and the hypertrophy of large arteries in ANG II-treated rats. Thus, prevention of hypertension is not enough for the attenuation of ANG II-induced hypertrophy of large arteries; abolition of sympathetic activity is also required.
An unexpected finding of our investigation has been the 'toxic' damage to small arteries in some of the ANG IItreated rats. Interestingly, this finding was observed equally commonly among hypertensive intact rats and essentially normotensive (but ANG II-treated) sympathectomized rats. It has been known for some time that excessive doses of ANG II can lead to vascular damage out of proportion to the prevailing blood pressure [21] .
Lesions include fibrinoid necrosis and medial hyperplasia of the smallest arteries. There is experimental evidence that this 'toxic' effect of ANG II is due to contraction of endothelial cells that allows the penetration of plasma proteins and platelets into the vessel wall, where they become deposited and cause necrosis or stimulate proliferation of smooth muscle cell [22, 23] . The exclusion of rats that displayed these lesions minimized the difference between small artery structures of ANG II-treated and control rats that we found. The present study provides further support for the hypothesis that these 'toxic' effects of ANG II are in part arterial-pressure-independent ones. When ANG II is administered to experimental animals in a long-term fashion as a model for benign essential hypertension in humans, the absence of such small artery lesions should ascertained. If 'toxic' damage is a frequent finding, the administered dose of ANG II should be reduced.
The principal limitation of the present investigation was the lack of continuous blood pressure measurements of rats. Such measurements may have revealed wide fluctuations of blood pressure in ANG II-treated sympathectomized rats into the hypertensive range during night-time activity that may have explained the development of structural changes in their small arteries. This is, however, not likely considering the extent of dissociation between blood pressure load and small artery structure, on the one hand, and between the response of small and large arteries, on the other, that was found for ANG II-treated sympathectomized and sham-sympathectomized rats. Another limitation of this study was our inability to characterize the nature of structural changes in small mesenteric arteries of ANG II-treated intact and sympathectomized rats. We had no assurance that the distribution of the variously sized small arteries was the same in treated and control rats. Lumen diameters of small arteries in rats of the four groups, therefore, were not compared. Without such a comparison, the relative contributions of remodeling and growth to the observed increase in WLR could not be estimated. Assuming that some growth took place, it is not known to what extent this was due to hypertrophy or hyperplasia of vascular muscle. Data from in-vivo experiments suggest that ANG II is a hypertrophic agent rather than a mitogen of vascular muscle [6, 10, 23] .
Sympathectomy attenuated the development of structural changes in large arteries but had no effect on the development of structural changes in small arteries of ANG IItreated rats. The trophic effect of ANG II on large arteries appears to be mediated in part through interaction with sympathetic nerves. Structural changes in small arteries, on the other hand, appear to be due to a direct trophic effect of ANG II.
